TECX Tectonic Therapeutic, Inc.

NEUTRAL Impact: 3/10 DEFA14A
Horizon weeks Filed Apr 24, 2026 Processed 1mo ago SEC 0001193125-26-177502
Proxy solicitation materials
Latest settled — T+20d ⚠ clustered
TECX ▲ +4.31% at T+20d
NEUTRAL call ✓ call won +4.31% · α vs SPY -0.64% · entry $28.75 → $29.99
Next anchor: T+60d in 5w
Currently $30.28 · +5.32% from $28.75 entry
Entry anchored
Apr 24, 03:59 PM ET
via Databento tick
T+1d
-5.39%
call -5.39% · α -4.91%
$27.20
settled 7w ago
T+5d
+3.13%
call +3.13% · α +2.73%
$29.65
settled 6w ago
T+20d
+4.31%
call +4.31% · α -0.64%
$29.99
settled 22d ago
T+60d
call — · α —
in 5w

Price Chart

Loading chart...

Executive Summary

Tectonic Therapeutic, Inc. (TECX) is holding its 2026 Annual Meeting to vote on the election of two directors (Timothy A. Springer and Stefan Vitorovic), the ratification of its auditor (Deloitte & Touche LLP), and the advisory approval of executive compensation. This filing is a definitive proxy statement from the company's management. A recent 8-K filing one day prior announced the appointment of a new board member, Jessica Chutter, indicating ongoing board changes.

Actionable Insight

Monitor the outcome of the shareholder vote, particularly the advisory vote on executive compensation, which can signal investor sentiment. The recent addition of a new board member suggests potential shifts in governance.

Key Facts

  • The DEFA14A filing is a definitive proxy statement from management for Tectonic Therapeutic, Inc.'s 2026 Annual Meeting.
  • Shareholders are voting on three main items: the election of two directors, the ratification of the auditor (Deloitte & Touche LLP), and the advisory approval of executive compensation.
  • A recent 8-K filing (one day prior) announced the appointment of a new board member, Jessica Chutter, to the board and audit committee, effective at this annual meeting.
  • The company's market cap is $534M, and there has been minimal recent insider activity (one sell totaling $31K in the last 30 days).

Financial Impact

No direct financial impact from the vote items. The appointment of a new board member may influence future governance.

Risk Factors

  • A low vote on executive compensation could signal investor dissatisfaction, though it is non-binding.
  • The recent board changes could lead to strategic shifts, but the overall impact is likely low for this routine filing.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-177502
Document: 0001193125-26-177502-index-headers.html0001193125-26-177502
Document: 0001193125-26-177502-index.html0001193125-26-177502
Document: 0001193125-26-177502.txt0001193125-26-177502
7 reports for TECX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for TECX — sortable, filterable
Type Now
Jun 11, 2026
1d ago
Institutional Cluster
BULLISH ★ 4/10
$28.89 awaiting T+20awaiting T+20$30.28 (+4.83%)
May 7, 2026
5w ago
8-K
BEARISH ★ 5/10
$29.00 $29.00· 0.00%▲ +0.02%$30.28 (−4.41%)
May 7, 2026
5w ago
Press Release
NEUTRAL ★ 4/10
$29.00 $29.00· 0.00%▼ −0.02%$30.28 (+4.41%)
Apr 24, 2026
7w ago
DEFA14A
NEUTRAL ★ 3/10
$28.75 $29.99▲ +4.31%▼ −0.64%$30.28 (+5.32%)
Apr 3, 2026
10w ago
3
NEUTRAL ★ 2/10
$29.98 $29.65▼ −1.10%▼ −10.08%$30.28 (+1.00%)
Mar 6, 2026
14w ago
Insider Cluster
NEUTRAL ★ 4/10
$35.87 $29.98▼ −16.42%▼ −14.38%$30.28 (−15.58%)
Feb 24, 2026
15w ago
8-K
NEUTRAL ★ 3/10
$23.11 $31.06▲ +34.40%▲ +39.64%$30.28 (+31.03%)
Showing 7 of 7

US Market Status

Market Closed — Opens Mon (49h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access